[fusion_builder_container hundred_percent=”yes” overflow=”visible”][fusion_builder_row][fusion_builder_column type=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”no” center_content=”no” min_height=”none”]
2018 marks 40 years since the FDA first approved cisplatin, a platinum-containing drug to treat cancer. This month’s edition of Periodic Graphics in Chemical & Engineering News looks at how it works and some of the other platinum-containing drugs that followed. Click through to see the full version of the graphic on the C&EN site.
For further detail on how chemists are fighting cancer resistance to platinum cancer drugs, check out this Chemunicate graphic.
[/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]
